TheBrief.Health

Long-Term Levothyroxine Use May Reduce CV Risk In Older Adults


Listen Later

Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.
...more
View all episodesView all episodes
Download on the App Store

TheBrief.HealthBy TheBrief.Health